Strides Pharma Science Limited has entered into a strategic partnership with Kenox Pharmaceuticals to jointly develop and commercialize a range of nasal sprays, marking a significant step in the specialty pharmaceutical segment. This collaboration aims to leverage Strides’ global distribution capabilities and Kenox’s research expertise in inhalation therapies. With growing demand for user-friendly drug delivery systems, particularly in respiratory and neurological care, the partnership is expected to strengthen both companies’ positions in regulated markets.